(Q53123731)

English

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

0 references

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

Rhett P. Ketterling

7

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

9

object named as

Ayalew Tefferi

1 reference

Europe PubMed Central

11 May 2018

author name string

Mrinal M Patnaik

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Terra L Lasho

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Christy M Finke

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Curtis A Hanson

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Janice M Hodnefield

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Ryan A Knudson

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Animesh Pardanani

8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

publication date

18 January 2013

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

American Journal of Hematology

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

88

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

201-206

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Risk assessment in chronic myelomonocytic leukemia (CMML).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SR proteins in vertical integration of gene expression from transcription to RNA processing to translation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

TET2 mutations in myelodysplasia and myeloid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Identifiers

10.1002/AJH.23373

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53123731&oldid=1534906735"